1416 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Devlin
    Devlin
  4. Papadopoulos
    Papadopoulos
  5. Landau
    Landau
  6. Shah
    Shah
  7. Jakubowski
    Jakubowski
  8. Castro-Malaspina
    Castro-Malaspina
  9. Scordo
    Scordo
  10. Sauter
    Sauter

Groups

  1. Bone Marrow Transplant (1416)
  2. Center for Hematologic Malignancies (1416)
  3. Department of Medicine (1416)
  4. Hematologic Malignancies, Division of (1372)
  5. Survivorship Research (749)
  6. GSK Faculty (482)
  7. CTCR Scholars (473)
  8. Epidemiology and Biostatistics (405)
  9. Biostatistics Service (391)
  10. Sloan Kettering Institute Faculty (382)
  1. "Meeting abstract"
  2. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (1416)
Groups
  1. Bone Marrow Transplant (1416)
  2. Center for Hematologic Malignancies (1416)
  3. Department of Medicine (1416)
  4. Hematologic Malignancies, Division of (1372)
  5. Survivorship Research (749)
  6. GSK Faculty (482)

More Groups

People
  1. Sergio Giralt (601)
  2. Miguel-Angel Perales (459)
  3. Sean Devlin (280)
  4. Esperanza Papadopoulos (263)
  5. Gunjan Shah (246)
  6. Heather Landau (246)

More People

Years
  1. 2023 (161)
  2. 2022 (113)
  3. 2021 (68)
  4. 2020 (98)
  5. 2019 (114)
  6. 2018 (105)

More Years

Publications
  1. Blood (680)
  2. Biology of Blood and Marrow Transplantation (315)
  3. Journal of Clinical Oncology (68)
  4. Bone Marrow Transplantation (64)
  5. Clinical Lymphoma, Myeloma and Leukemia (52)
  6. Transplantation and Cellular Therapy (28)

More Publications

Publishers
  1. American Society of Hematology (680)
  2. Elsevier Inc. (403)
  3. Nature Publishing Group (72)
  4. American Society of Clinical Oncology (68)
  5. Wiley Blackwell (31)
  6. Elsevier Science, Inc. (26)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment outcomes and prognostic factors with lenalidomide, bortezomib, and dexamethasone (RVd) alone versus RVd plus autologous stem cell transplantation (ASCT) in African American (AA) patients (pts) with newly diagnosed multiple myeloma (NDMM) in the DETERMINATION phase 3 trial
    Meeting Abstract

    Houde, C. A.; Khan, A.; Jacobus, S. J.; Hassoun, H.; Anderson, L. D. Jr; Merz, L. E.; Zon, R. L.; Efebera, Y.; Buck, T.; Innis-Shelton, R. D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Hepatic response and progression criteria in light chain amyloidosis: A multicenter validation study
    Meeting Abstract

    Muchtar, E.; Palladini, G.; Schonland, S.; Dispenzieri, A.; Wisniowski, B.; Merlini, G.; Milani, P.; Hegenbart, U.; Dittrich, T.; Kastritis, E.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-world tisagenlecleucel outcomes in Richter-transformed chronic lymphocytic leukemia: A Center for International Blood & Marrow Transplant Research (CIBMTR) analysis
    Meeting Abstract

    Shadman, M.; Frigault, M. J.; Foley, S. R.; Hill, B. T.; Schofield, G.; Jacobson, C.; Jaglowski, S. M.; Locke, F. L.; Landsburg, D. J.; Ram, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T-cell (CAR-T) therapy in secondary central nervous system large B-cell lymphoma (SCNSL): A multicenter retrospective analysis
    Meeting Abstract

    Ahmed, G.; Alsouqi, A.; Szabo, A.; Rojek, A. E.; Riedell, P. A.; Awan, F. T.; Samples, L.; Shadman, M.; Hu, M.; Bachanova, V.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Idecabtagene vicleucel (ide-cel) versus standard (std) regimens in patients (pts) with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): Analysis of cytopenias and infections in pts from KarMMa-3
    Meeting Abstract

    Baz, R.; Otero, P. R.; Ailawadhi, S.; Arnulf, B.; Patel, K. K.; Nooka, A. K.; Costa, L.; Raje, N. S.; Abrahamsen, I. W.; Delforge, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Durable efficacy and manageable safety in patients ageā‰„75 years with relapsed/refractory large B-cell lymphoma treated with tisagenlecleucel in the real-world setting
    Meeting Abstract

    Landsburg, D. J.; Heim, M.; Moskop, A.; Foley, S. R.; Hill, B. T.; Schofield, G.; Jacobson, C.; Jaglowski, S. M.; Locke, F. L.; Ram, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • High-dose targeted radiation with (131)I-apamistamab prior to HCT demonstrated a dose-response for durable complete remission in patients with R/R AML
    Meeting Abstract

    Litzow, M. R.; Chen, G.; Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Abboud, C. N.; Koshy, N.; Tomlinson, B. K.; Abhyankar, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Preconditioning single high-dose palifermin alters the posttransplant inflammatory cytokine profile
    Meeting Abstract

    Schulz, E.; Holtzman, N. G.; Ostojic, A.; Pirsl, F.; Steinberg, S. M.; Curtis, L. M.; Shaffer, B. C.; Heller, T.; Carpenter, A.; Hakim, F. T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Efficacy of brentuximab vedotin maintenance therapy following autologous stem cell transplantation in patients with relapsed/refractory classical Hodgkin lymphoma with and without pre-transplant exposure to novel agents
    Meeting Abstract

    Falade, A. S.; Redd, R. A.; Shah, H.; Baron, K.; Iyengar, S.; Desai, S. H.; Ansell, S. M.; Micallef, I.; Nedved, A.; Ganesan, N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Engraftment syndrome during autologous stem cell transplant in Hodgkin lymphoma patients treated with checkpoint inhibitors: A multi-center retrospective analysis
    Meeting Abstract

    Taranto, E.; Hwang, W. T.; Alfaro, M.; Surapaneni, A. S.; Gill, S. K.; Feldman, T.; Randall, M. P.; Spinner, M. A.; Furqan, F.; Shah, N. N.; more...
    Blood (2023)

    Fulltext@MSK | Save